| PDL size categories . | Risk of thromboembolism . | Number of studies; observed heterogeneity . |
|---|---|---|
| PDL > 5 mm PDL = 0–5 mm no PDL | OR = 4.37, 95% CI: 1.74–10.97, P = .002 OR = 1.38, 95% CI: 1.11–1.71, P = .003 Reference group | 10 studies; I2 = 35% 15 studies; I2 = 5% Reference group |
| PDL 0–5 mm PDL > 5 mm | OR = 1.16, 95% CI: 0.67–2.06, P = .603 Reference group | 9 studies; I2 = 2% |
| PDL > 3 mm PDL = 1–3 mm PDL < 1 mm or no PDL | OR = 3.27, 95% CI: 1.27–8.43, P = .014 OR = 1.78, 95% CI: 0.97–3.27, P = .061 Reference group | 9 studies; I2 = 13% 8 studies; I2 = 0% Reference group |
| PDL 1–3 mm PDL > 3 mm | OR = 1.73, 95% CI: 0.38–7.91, P = .482 Reference group | 5 studies; I2 = 39% |
| PDL > 5 mm PDL = 3–5 mm PDL < 3 mm or no PDL | OR = 5.03, 95% CI: 1.09–24.78, P = .047 OR = 3.31, 95% CI: 1.03–10.61, P = .040 Reference group | 6 studies; I2 = 44% 7 studies; I2 = 45% Reference group |
| PDL 3–5 mm PDL > 5 mm | OR = 1.05, 95% CI: 0.24–19.35, P = .932 Reference group | 4 studies; I2 = 48% |
| PDL size categories . | Risk of thromboembolism . | Number of studies; observed heterogeneity . |
|---|---|---|
| PDL > 5 mm PDL = 0–5 mm no PDL | OR = 4.37, 95% CI: 1.74–10.97, P = .002 OR = 1.38, 95% CI: 1.11–1.71, P = .003 Reference group | 10 studies; I2 = 35% 15 studies; I2 = 5% Reference group |
| PDL 0–5 mm PDL > 5 mm | OR = 1.16, 95% CI: 0.67–2.06, P = .603 Reference group | 9 studies; I2 = 2% |
| PDL > 3 mm PDL = 1–3 mm PDL < 1 mm or no PDL | OR = 3.27, 95% CI: 1.27–8.43, P = .014 OR = 1.78, 95% CI: 0.97–3.27, P = .061 Reference group | 9 studies; I2 = 13% 8 studies; I2 = 0% Reference group |
| PDL 1–3 mm PDL > 3 mm | OR = 1.73, 95% CI: 0.38–7.91, P = .482 Reference group | 5 studies; I2 = 39% |
| PDL > 5 mm PDL = 3–5 mm PDL < 3 mm or no PDL | OR = 5.03, 95% CI: 1.09–24.78, P = .047 OR = 3.31, 95% CI: 1.03–10.61, P = .040 Reference group | 6 studies; I2 = 44% 7 studies; I2 = 45% Reference group |
| PDL 3–5 mm PDL > 5 mm | OR = 1.05, 95% CI: 0.24–19.35, P = .932 Reference group | 4 studies; I2 = 48% |
Using one category as reference, the comparative prognostic difference of the remaining categories, in terms of thromboembolic risk, was calculated. For example, compared with patients with no PDL or PDL of 0–1 mm, those with PDL of 1–3 mm are 1.78 times more likely to have a thromboembolic event, while those with PDL of >3 mm are 3.27 times more likely to have a thromboembolic event.
CI, confidence interval; I2, heterogeneity statistic; OR, odds ratio; PDL, peri-device leak.
| PDL size categories . | Risk of thromboembolism . | Number of studies; observed heterogeneity . |
|---|---|---|
| PDL > 5 mm PDL = 0–5 mm no PDL | OR = 4.37, 95% CI: 1.74–10.97, P = .002 OR = 1.38, 95% CI: 1.11–1.71, P = .003 Reference group | 10 studies; I2 = 35% 15 studies; I2 = 5% Reference group |
| PDL 0–5 mm PDL > 5 mm | OR = 1.16, 95% CI: 0.67–2.06, P = .603 Reference group | 9 studies; I2 = 2% |
| PDL > 3 mm PDL = 1–3 mm PDL < 1 mm or no PDL | OR = 3.27, 95% CI: 1.27–8.43, P = .014 OR = 1.78, 95% CI: 0.97–3.27, P = .061 Reference group | 9 studies; I2 = 13% 8 studies; I2 = 0% Reference group |
| PDL 1–3 mm PDL > 3 mm | OR = 1.73, 95% CI: 0.38–7.91, P = .482 Reference group | 5 studies; I2 = 39% |
| PDL > 5 mm PDL = 3–5 mm PDL < 3 mm or no PDL | OR = 5.03, 95% CI: 1.09–24.78, P = .047 OR = 3.31, 95% CI: 1.03–10.61, P = .040 Reference group | 6 studies; I2 = 44% 7 studies; I2 = 45% Reference group |
| PDL 3–5 mm PDL > 5 mm | OR = 1.05, 95% CI: 0.24–19.35, P = .932 Reference group | 4 studies; I2 = 48% |
| PDL size categories . | Risk of thromboembolism . | Number of studies; observed heterogeneity . |
|---|---|---|
| PDL > 5 mm PDL = 0–5 mm no PDL | OR = 4.37, 95% CI: 1.74–10.97, P = .002 OR = 1.38, 95% CI: 1.11–1.71, P = .003 Reference group | 10 studies; I2 = 35% 15 studies; I2 = 5% Reference group |
| PDL 0–5 mm PDL > 5 mm | OR = 1.16, 95% CI: 0.67–2.06, P = .603 Reference group | 9 studies; I2 = 2% |
| PDL > 3 mm PDL = 1–3 mm PDL < 1 mm or no PDL | OR = 3.27, 95% CI: 1.27–8.43, P = .014 OR = 1.78, 95% CI: 0.97–3.27, P = .061 Reference group | 9 studies; I2 = 13% 8 studies; I2 = 0% Reference group |
| PDL 1–3 mm PDL > 3 mm | OR = 1.73, 95% CI: 0.38–7.91, P = .482 Reference group | 5 studies; I2 = 39% |
| PDL > 5 mm PDL = 3–5 mm PDL < 3 mm or no PDL | OR = 5.03, 95% CI: 1.09–24.78, P = .047 OR = 3.31, 95% CI: 1.03–10.61, P = .040 Reference group | 6 studies; I2 = 44% 7 studies; I2 = 45% Reference group |
| PDL 3–5 mm PDL > 5 mm | OR = 1.05, 95% CI: 0.24–19.35, P = .932 Reference group | 4 studies; I2 = 48% |
Using one category as reference, the comparative prognostic difference of the remaining categories, in terms of thromboembolic risk, was calculated. For example, compared with patients with no PDL or PDL of 0–1 mm, those with PDL of 1–3 mm are 1.78 times more likely to have a thromboembolic event, while those with PDL of >3 mm are 3.27 times more likely to have a thromboembolic event.
CI, confidence interval; I2, heterogeneity statistic; OR, odds ratio; PDL, peri-device leak.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
